2,4-二氯苯基碘化镁 | 105459-84-5

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 中文名称: 2,4-二氯苯基碘化镁
• 英文名称: 2,4-dichlorophenyl magnesium iodide
• 英文别名: 2,4-dichlorophenylmagnesium iodide
• CAS: 105459-84-5
• 化学式: C₆H₃Cl₂IMg
• 分子量: 297.205
• InChiKey: GXUQLLANSDDIKI-UHFFFAOYSA-M

计算性质

• 辛醇/水分配系数(LogP)：
  2.67
• 重原子数：
  10.0
• 可旋转键数：
  1.0
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.0
• 拓扑面积：
  0.0
• 氢给体数：
  0.0
• 氢受体数：
  0.0

反应信息

• 作为反应物：
  描述：

  2,4-二氯苯基碘化镁 、 1-苯基-1-(1,2,4-三唑-1-基)丙烷-2-酮 以 乙醚 为溶剂， 反应 2.0h， 以27%的产率得到(2R,3R/2S,3S)-2-(2,4-Dichlorphenyl)-3-phenyl-3-(1H-1,2,4-triazol-1-yl)-2-propanol
  参考文献：
  名称：

  Buschmann, Ernst; Zeeh, Bernd; Goetz, Norbert, Liebigs Annalen der Chemie, 1987, p. 349 - 355

  摘要：

  DOI：

文献信息

• Oxindole derivative
  申请人：Sumitomo Pharmaceuticals Co., Ltd.

  公开号：US06576656B1

  公开（公告）日：2003-06-10

  An oxindole of Formula 1 or a prodrug thereof, or a pharmaceutically acceptable salt thereof is useful for growth hormone releaser: wherein R1, R2, R3 and R4 are independently hydrogen, optionally substituted alkyl etc; R5 is optionally substituted aryl or optionally substituted heteroaryl; Z is —O— or —NH—; one of W1 and W2 is hydrogen, alkyl or —Y—CON(R10)R11; the other of W1 and W2 is n is 1, 2 or 3; m is 0, 1, 2 or 3; Y is single bond or C1-C3 alkylene; R6 and R7 are independently hydrogen, optionally substituted alkyl etc; R8 and R9 are independently hydrogen, optionally substituted alkyl etc; R10 and R11 are independently hydrogen, alkyl etc.

  Formula 1的氧吲哚或其前药，或其药学上可接受的盐对生长激素释放剂有用： 其中 R1、R2、R3和R4独立地是氢、可选择地取代的烷基等； R5是可选择地取代的芳基或可选择地取代的杂环芳基； Z是—O—或—NH—； W1和W2中的一个是氢、烷基或—Y—CON(R10)R11； 另一个是 n为1、2或3；m为0、1、2或3； Y是单键或C1-C3烷基； R6和R7独立地是氢、可选择地取代的烷基等； R8和R9独立地是氢、可选择地取代的烷基等； R10和R11独立地是氢、烷基等。
• Antifungal 1-aryl-1-fluoroalkyl-2-(1H-1,2,4-triazol-1-yl)ethanols
  申请人：Pfizer Inc.

  公开号：US04616027A1

  公开（公告）日：1986-10-07

  Compounds of the general formula ##STR1## or a pharmaceutically or agriculturally acceptable acid addition salt thereof wherein R is 5-chloro-2-pyridyl, phenyl or phenyl substituted by from one to three substituents, each independently selected from F, Cl, Br, I, CF.sub.3, (C.sub.1 -C.sub.4)alkyl and (C.sub.1 -C.sub.4)alkoxy; and n is zero or an integer from 1 to 5; method for their use in combatting fungal infections in plants, seeds and animals, including humans; and pharmaceutical and agricultural compositions containing them.

  通用公式##STR1##的化合物或其药学或农业可接受的酸盐，其中R为5-氯-2-吡啶基、苯基或苯基，其上取代一个至三个取代基，每个取代基可独立选择自F、Cl、Br、I、CF.sub.3、(C.sub.1-C.sub.4)烷基和(C.sub.1-C.sub.4)烷氧基；n为零或1至5的整数；其在植物、种子和动物（包括人类）中用于对抗真菌感染的方法；以及含有它们的药用和农业组合物。
• OXINDOLE DERIVATIVE AS FEEDING CONTROL AGENT
  申请人：Tokunaga Teruhisa

  公开号：US20090131398A1

  公开（公告）日：2009-05-21

  Disclosed is a compound represented by the formula (1) below, a prodrug thereof or a pharmaceutically acceptable salt of either, which is useful as a therapeutic, preventive or ameliorating agent for diabetes and the like. (In the formula, R 3 represents an optionally substituted carbamoyl group or the like; X represents a hydroxyl group or the like; W 1 and W 2 independently represent a single bond or methylene; R 7 and R 8 independently represent a hydrogen atom, an optionally substituted alkyl group or the like; and Ar represents an optionally substituted aryl group or the like.)

  本发明揭示了一种化合物，其化学式表示为(1)，或其前药或药学上可接受的盐，用作治疗、预防或改善糖尿病等疾病的治疗剂、预防剂或改善剂。（其中，R3代表可选取代的氨基甲酰基或类似基团；X代表羟基或类似基团；W1和W2独立地代表单键或亚甲基；R7和R8独立地代表氢原子、可选取代的烷基或类似基团；Ar代表可选取代的芳基或类似基团。）
• Oxindole derivative as feeding control agent
  申请人：Dainippon Sumitomo Pharma Co., Ltd.

  公开号：US07825155B2

  公开（公告）日：2010-11-02

  Disclosed is a compound represented by the formula (1) below, a prodrug thereof or a pharmaceutically acceptable salt of either, which is useful as a therapeutic, preventive or ameliorating agent for diabetes and the like. (In the formula, R3 represents an optionally substituted carbamoyl group or the like; X represents a hydroxyl group or the like; W1 and W2 independently represent a single bond or methylene; R7 and R8 independently represent a hydrogen atom, an optionally substituted alkyl group or the like; and Ar represents an optionally substituted aryl group or the like.)

  本发明涉及一种化合物，其化学式（1）如下，以及其前药或其药学上可接受的盐，其可用作治疗、预防或改善糖尿病等疾病的治疗剂。（在该式中，R3代表可选取代的氨基甲酰基或类似基团；X代表羟基或类似基团；W1和W2独立地代表单键或亚甲基；R7和R8独立地代表氢原子、可选取代的烷基或类似基团；Ar代表可选取代的芳基或类似基团。）
• Triazole and imidazole compounds, process for their preparation and their use as fungicides and plant growth regulators, and intermediates for their synthesis
  申请人：IMPERIAL CHEMICAL INDUSTRIES PLC

  公开号：EP0099165A1

  公开（公告）日：1984-01-25

  wherein R1 is hydrogen, alkyl, cycloalkyl, heterocyclyl, or aryl or aralkyl both optionally substituted with halogen, nitro, alkyl, haloalkyl, alkoxy, phenyl, phenoxy, halophenyl, or haloalkoxy; R2 is hydrogen, alkyl, alkenyl, alkynyl, aralkyl or acyl; R3 and R4, which may be the same or different, are hydrogen, alkyl, alkenyl, or optionally substituted aryl; W is N or CH; X is -CO2R5, -CONR6R7, -CN, -CHO, 4,4-dimethyl-Δ2-oxazolin-2-yl, or 4,4,6-trimethyl-5,6-dihydro-1,3-oxazin-2-yl; R5, R6 and R7, which may be the same or different, are hydrogen, optionally substituted alkyl, optionally substituted aralkyl, alkenyl, or optionally substituted aryl; and their acid addition salts and metal complexes. The compounds have fungicidal activity and plant growth regulating activity.

  其中 R1 是氢、烷基、环烷基、杂环烷基或芳基或芳烷基，两者可任选被卤素、硝基、烷基、卤代烷基、烷氧基、苯基、苯氧基、卤代苯基或卤代烷氧基取代；R2 是氢、烷基、烯基、炔基、芳烷基或酰基；R3 和 R4 可以相同或不同，是氢、烷基、烯基或任选取代的芳基；W是N或CH；X是-CO2R5、-CONR6R7、-CN、-CHO、4,4-二甲基-Δ2-恶唑啉-2-基或4,4,6-三甲基-5,6-二氢-1,3-恶嗪-2-基；R5、R6和R7可以相同或不同，是氢、任选取代的烷基、任选取代的芳基、烯基或任选取代的芳基；以及它们的酸加成盐和金属络合物。这些化合物具有杀菌活性和植物生长调节活性。